Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mats O Karlsson

Showing results (1-10 of 336) with videos related to

Pageof 34
Sort By:
Clinical Pharmacology and Therapeutics|May 19, 2025
In the Cradle of Pharmacometric Methodology: Introducing Population PKPD Modeling, Simultaneous Analysis, and the Effect-Compartment Model-Commentary on Sheiner et alMats O Karlsson
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 28, 2005
Estimation of dosing strategies aiming at maximizing utility or responder probability, using oxybutynin as an example drugSiv Jönsson, Mats O Karlsson
The AAPS Journal|May 20, 2009
Handling data below the limit of quantification in mixed effect modelsMartin Bergstrand, Mats O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics|March 7, 2014
Concordance between criteria for covariate model buildingStefanie Hennig, Mats O Karlsson
The AAPS Journal|June 22, 2017
A Minimal Continuous-Time Markov Pharmacometric ModelEmilie Schindler, Mats O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics|November 26, 2020
Improved numerical stability for the bounded integer modelSebastian Ueckert, Mats O Karlsson
The AAPS Journal|January 25, 2024
Comparison of Two Methods for Determining Item Characteristic Functions and Latent Variable Time-Course for Pharmacometric Item Response ModelsLeticia Arrington, Mats O Karlsson
Clinical Pharmacology and Therapeutics|January 25, 2003
A rational approach for selection of optimal covariate-based dosing strategiesSiv Jönsson, Mats O Karlsson
Pharmaceutical Research|January 14, 2003
Impact of omission or replacement of data below the limit of quantification on parameter estimates in a two-compartment modelVincent Duval, Mats O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics|October 12, 2012
Letter to the editor regarding: "a reduction in between subject variability is not mandatory for selecting a new covariate"Mats O Karlsson, Martin Bergstrand
Pageof 34

Showing results (1-10 of 336) with videos related to

Sort By:
Pageof 34
Clinical Pharmacology and Therapeutics|May 19, 2025
In the Cradle of Pharmacometric Methodology: Introducing Population PKPD Modeling, Simultaneous Analysis, and the Effect-Compartment Model-Commentary on Sheiner et alMats O Karlsson
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 28, 2005
Estimation of dosing strategies aiming at maximizing utility or responder probability, using oxybutynin as an example drugSiv Jönsson, Mats O Karlsson
The AAPS Journal|May 20, 2009
Handling data below the limit of quantification in mixed effect modelsMartin Bergstrand, Mats O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics|March 7, 2014
Concordance between criteria for covariate model buildingStefanie Hennig, Mats O Karlsson
The AAPS Journal|June 22, 2017
A Minimal Continuous-Time Markov Pharmacometric ModelEmilie Schindler, Mats O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics|November 26, 2020
Improved numerical stability for the bounded integer modelSebastian Ueckert, Mats O Karlsson
The AAPS Journal|January 25, 2024
Comparison of Two Methods for Determining Item Characteristic Functions and Latent Variable Time-Course for Pharmacometric Item Response ModelsLeticia Arrington, Mats O Karlsson
Clinical Pharmacology and Therapeutics|January 25, 2003
A rational approach for selection of optimal covariate-based dosing strategiesSiv Jönsson, Mats O Karlsson
Pharmaceutical Research|January 14, 2003
Impact of omission or replacement of data below the limit of quantification on parameter estimates in a two-compartment modelVincent Duval, Mats O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics|October 12, 2012
Letter to the editor regarding: "a reduction in between subject variability is not mandatory for selecting a new covariate"Mats O Karlsson, Martin Bergstrand
Pageof 34